Arboviral infections such as Zika, chikungunya, dengue,
and yellow
fever pose significant health problems globally. The population at
risk is expanding with the geographical distribution of the main transmission
vector of these viruses, the
Aedes aegypti
mosquito. The global spreading of this mosquito is driven by human
migration, urbanization, climate change, and the ecological plasticity
of the species. Currently, there are no specific treatments for
Aedes
-borne infections. One strategy to combat different
mosquito-borne arboviruses is to design molecules that can specifically
inhibit a critical host protein. We obtained the crystal structure
of 3-hydroxykynurenine transaminase (AeHKT) from
A.
aegypti
, an essential detoxification enzyme of the
tryptophan metabolism pathway. Since AeHKT is found exclusively in
mosquitoes, it provides the ideal molecular target for the development
of inhibitors. Therefore, we determined and compared the free binding
energy of the inhibitors 4-(2-aminophenyl)-4-oxobutyric acid (4OB)
and sodium 4-(3-phenyl-1,2,4-oxadiazol-5-yl)butanoate (OXA) to AeHKT
and AgHKT from
Anopheles gambiae
, the
only crystal structure of this enzyme previously known. The cocrystallized
inhibitor 4OB binds to AgHKT with
K
i
of
300 μM. We showed that OXA binds to both AeHKT and AgHKT enzymes
with binding energies 2-fold more favorable than the crystallographic
inhibitor 4OB and displayed a 2-fold greater residence time τ
upon binding to AeHKT than 4OB. These findings indicate that the 1,2,4-oxadiazole
derivatives are inhibitors of the HKT enzyme not only from
A. aegypti
but also from
A. gambiae
.